Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MCIT Rule Likely Too Broken For CMS To Implement In December, Analyst Predicts

Executive Summary

John Leppard with Washington Analysis says the Medicare agency’s recent delay of the MCIT breakthrough devices rule until mid-December suggests the CMS will likely scrap it altogether and start from scratch.

You may also be interested in...



CMS Proposes New TCET Pathway, But How Much Difference Will It Make?

While many industry groups have praised the introduction of TCET, a replacement for the repealed MCIT rule, a Washington Analysis expert has his doubts.

Cures 2.0 Throws MCIT A Lifeline, And More

The second 21st Century Cures Act includes a provision to force the US Medicare agency to cover breakthrough medical devices for elderly patients, among other mandates.

CMS Dashes Industry Hopes For MCIT Rule Any Time Soon

The US Medicare agency has proposed to withdraw a rule that would give temporary automatic coverage to breakthrough devices, stating the rule doesn’t meet its evidence threshold and could put patients at risk.­­­­­­­

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT143943

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel